Comparing the cost-effectiveness of SGLT2i versus mineralocorticoid antagonists

FHS
June 19, 2023
2:43 pm

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are approved for heart failure with reduced ejection fraction (HFrEF).

Natural Medicine Advisory Bulletin 11: March & April 2024 – Psychedelic Alpha

A. License Types, Qualifications, Procedures, and Financial Interests The Natural Medicine Division’s first set of draft rules focuses on the overall licensing framework for Natural

April 29, 2024

Study detects biomarker changes nearly 30 years before symptom onset of Alzheimer’s disease

A new paper has shown how Alzheimer’s disease pathology comes into being over a period of almost three decades.

August 10, 2023

As wildfires burn, scientists race to understand the health dangers of prolonged exposure

More than 120 million Americans — one-third of the U.S. population — have been living under air quality alerts this summer, with citizens in New

July 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.